Mechanism of Action Study for Psoriasis

NCT00932113 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Methotrexate
DRUG: Adalimumab (Humira)

Sponsor

Tufts Medical Center